A guide to generating and using hiPSC derived NPCs for the study of neurological diseases.
Post-mortem studies of neurological diseases are not ideal for identifying the underlying causes of disease initiation, as many diseases include a long period of disease progression prior to the onset of symptoms. Because fibroblasts from patients and healthy controls can be efficiently reprogrammed into human induced pluripotent stem cells (hiPSCs), and subsequently differentiated into neural progenitor cells (NPCs) and neurons for the study of these diseases, it is now possible to recapitulate the developmental events that occurred prior to symptom onset in patients. We present a method by which to efficiently differentiate hiPSCs into NPCs, which in addition to being capable of further differentiation into functional neurons, can also be robustly passaged, freeze-thawed or transitioned to grow as neurospheres, enabling rapid genetic screening to identify the molecular factors that impact cellular phenotypes including replication, migration, oxidative stress and/or apoptosis. Patient derived hiPSC NPCs are a unique platform, ideally suited for the empirical testing of the cellular or molecular consequences of manipulating gene expression.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai.
Aaron
A
Topol
Department of Psychiatry, Icahn School of Medicine at Mount Sinai.
Ngoc N
NN
Tran
Department of Psychiatry, Icahn School of Medicine at Mount Sinai; Department of Neuroscience, Icahn School of Medicine at Mount Sinai; kristen.brennand@mssm.edu.
Kristen J
KJ
Brennand
D002454:Cell Differentiation / Q000502:physiology; D003584:Cytological Techniques / Q000379:methods*; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology*; D009422:Nervous System Diseases / Q000473:pathology*; D058953:Neural Stem Cells / Q000166:cytology*